Point72 Hong Kong’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,175
| Closed | -$64.7K | – | 510 |
|
|
2024
Q4 | $64.7K | Buy |
+3,175
| New | +$64.7K | ﹤0.01% | 316 |
|
|
2022
Q4 | – | Sell |
-4,753
| Closed | -$146K | – | 383 |
|
|
2022
Q3 | $146K | Buy |
+4,753
| New | +$146K | 0.01% | 633 |
|
|
2022
Q2 | – | Sell |
-1,194
| Closed | -$38K | – | 1557 |
|
|
2022
Q1 | $38K | Sell |
1,194
-125
| -9% | -$3.98K | ﹤0.01% | 919 |
|
|
2021
Q4 | $59K | Buy |
1,319
+420
| +47% | +$18.8K | ﹤0.01% | 757 |
|
|
2021
Q3 | $45K | Buy |
+899
| New | +$45K | ﹤0.01% | 943 |
|
|
2020
Q2 | – | Sell |
-120
| Closed | -$2K | – | 1193 |
|
|
2020
Q1 | $2K | Buy |
+120
| New | +$2K | ﹤0.01% | 843 |
|
|
2018
Q1 | – | Sell |
-13,043
| Closed | -$204K | – | 956 |
|
|
2017
Q4 | $204K | Buy |
+13,043
| New | +$204K | 0.16% | 55 |
|